Ask AI

ClinicalThought

Share

Program Content

Activities

  • CDK46i in EBC
    Closing the Gap Between Evidence and Practice: Adjuvant CDK4/6 Inhibitors in High-Risk HR-Positive/HER2-Negative Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 28, 2026

Provided by

ProCE Banner

Provided by National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

This activity is supported by educational grants from Lilly and Novartis.

Lilly

Novartis

Partners

Decera Clinical Education

ProCE Banner